For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Switching blood pressure medications – it’s time to break the cilazapril habit
+Practice
In print
HEARTBEAT
Switching blood pressure medications – it’s time to break the cilazapril habit
Wednesday 26 May 2021, 12:35 AM

Switching blood pressure medications – it’s time to break the cilazapril habit
Last year, cilazapril with hydrochlorothiazide was discontinued, and now cilazapril alone is no longer funded for new patients. Consultant cardiologist Chris Ellis discusses what to do when patients with hypertension run out of their supply of these medications
Key Points, With recent changes to the funding of cilazapril, now is the time to switch patients to another medicine for treatment of hypertension.
Angiotensin , Pract Green w Pale Yellow
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.
References
Messerli FH, Bangalore S, Bavishi C, et al. Angiotensinconverting enzyme inhibitors in hypertension: To use or not to use? J Am Coll Cardiol 2018;71(13):1474–82.